Overview
Medapp is a company that develops 3D imaging technology and artificial intelligence for the medical field, specifically through its product CarnaLife Holo, which has received FDA certification. The company participates in medical technology exhibitions and collaborates with leading hospitals, such as the Medical University of Warsaw, for advanced medical procedures like heart ablation.
Financials
The financial statement for 2022 has not yet been filed with the Financial Document Repository (past deadline).
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Stock quotes
- Open
- PLN 0.17
- High
- PLN 0.18
- Low
- PLN 0.17
- Volume
- 18.37K
- Avg. vol.
- 41.13K
- Market cap
- PLN 44.77M
- P/E ratio
- —
- EPS
- -PLN 0.01
- Shares outstanding
- 250.13M
- 52-week
- PLN 0.16 – 0.18
- Dividend yield
- —
- Dividend
- —
- Ex dividend date
- —
- ISIN
- PLYLWHT00012
- Exchange
- NewConnect
Quarterly results
| Period | Revenue | EBIT | Net profit |
|---|---|---|---|
| Q2 2026 | USD 819.56k | USD 302.54k | USD 291.46k |
| Q1 2026 | USD 798.22k | USD 139.38k | USD 131.82k |
| Q4 2025 | USD 203.16k | USD 132.60k | USD -22.60k |
| Q3 2025 | USD 246.86k | USD -154.70k | USD -189.10k |
Results for Q3 2026:Nov 13, 2026
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2021.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2010-11-26. Active
16 1090 2590 0000 0001 5568 2187
43 1020 4027 0000 1102 1839 2359- 47 1090 2590 0000 0001 5568 2308
Debt
3 active proceedings recorded in KRZ. Active proceeding
| Registration date | Proceeding type | Status | |
|---|---|---|---|
| Jan 27, 2026 | Accelerated arrangement proceedings | In progress | |
| Dec 29, 2025 | Petition to open accelerated arrangement proceedings | Closed | |
| Nov 19, 2025 | Petition to declare entrepreneur bankruptcy | Closed |
Public aid
22 public aid cases recorded, with a total value of $1,587,532.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jan 9, 2026 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $191$191 | Prezes Zakładu Ubezpieczeń Społecznych | |
| Sep 7, 2023 | Aid for research and development projects: industrial research | $544.1K$544,140 | Dyrektor Narodowego Centrum Badań i Rozwoju | |
| Aug 14, 2023 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $929$929 | Prezes Zakładu Ubezpieczeń Społecznych |
European Funds
4 EU budget awards (FTS) recorded, totalling $1,441,013.
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2024-10-01 | 101161333 - Vrhealthchampions - we are health champions - disrupting the european healthcare systems with virtual reality and augmented reality applications | $677.6K$677,600 | 2.1.11 - European Regional Development Fund (ERDF) | |
| 2024-01-01 | 101119884 - Rebone - end-to-end multidisciplinary optimal design for improved personalized bioactive glass/ceramic bone substitute implants | $229.2K$229,204 | 1.0.11 - Horizon Europe | |
| 2024-01-01 | 101119884 - Rebone - end-to-end multidisciplinary optimal design for improved personalized bioactive glass/ceramic bone substitute implants | $15,672$15,672 | 1.0.11 - Horizon Europe |
Tenders
No recorded participation in tenders.
Authorized Representatives
Manner of representation
In the case of a multi-member management board, declarations of will on behalf of the company must be made by two members of the management board acting jointly, or by two commercial proxies. In the case of a one-person management board, the sole member of the management board is independently authorized to make declarations of will on behalf of the company.
Supervisory board
Beneficial owners
| Person | Rights | |
|---|---|---|
Wiktoria Guzik (30)  | Prezes zarządu oraz jedyny beneficjent doktor guzik fundacja rodzinna, która posiada 51,81% akcji spółki |
Subsidiaries
| Name | Share value | Stake | ||
|---|---|---|---|---|
Medapp Clinical Researchsp. z o.o. | 27,012,425.72 USD | 100% | ||
Medapp Aisp. z o.o. | 21,576,202.05 USD | 100% | ||
Medapp Clinicssp. z o.o. | 18,711,844.95 USD | 96.4495% |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| ArdigenS.A. | $12,513,309.89 | ardigen.com | ||
| MedicalgorithmicsS.A. | $7,566,549.47 | medicalgorithmics.com | ||
| Sidlysp. z o.o. | $4,977,649.42 | sidly.eu | ||
| Scope FluidicsS.A. | $3,082,936.61 | scopefluidics.com | ||
| BiotechnaS.A. | $2,472,888.07 | bsbiotechna.com | ||
| FamicordtxS.A. | $1,365,068.41 | famicordtx.com | ||
| Saventic Healthsp. z o.o. | $1,089,246.05 | saventic.com | ||
| Ecoverseasp. z o.o. | $891,022.45 | coslab.pl | ||
| MedisensonicS.A. | $362,572.63 | medisensonic.com | ||
| BiocamS.A. | $327,799.68 | biocam.ai |
Change history
| Date | Event | |
|---|---|---|
| 2024-04-18 | Address change (Armii Krajowej 25, 30-150, Kraków → Aleja Juliusza Słowackiego 6/10, 30-037, Kraków) | |
| 2022-06-24 | Share capital change (25,003,220.40 PLN → 25,013,245.40 PLN) | |
| 2021-07-28 | Address change (Aleja Płk. Władysława Beliny-Prażmowskiego 60, 31-514, Kraków → Armii Krajowej 25, 30-150, Kraków) | |
| 2021-07-08 | Share capital change (24,716,094.00 PLN → 25,003,220.40 PLN) | |
| 2020-12-01 | Share capital change (23,919,094.30 PLN → 24,716,094.00 PLN) |
FAQ
Last updated: 2026-03-23